Geneos Wealth Management’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.22K | Buy |
50
+11
| +28% | +$1.15K | ﹤0.01% | 2561 |
|
|
2025
Q1 | $7.93K | Buy |
39
+16
| +70% | +$3.25K | ﹤0.01% | 2636 |
|
|
2024
Q4 | $1.95K | Hold |
23
| – | – | ﹤0.01% | 2601 |
|
|
2024
Q3 | $2.07K | Buy |
+23
| New | +$2.07K | ﹤0.01% | 2292 |
|
|
2020
Q1 | – | Sell |
-2,406
| Closed | -$245K | – | 2477 |
|
|
2019
Q4 | $245K | Buy |
+2,406
| New | +$245K | 0.01% | 617 |
|